We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
The Clinical and Molecular Genetics department consists of: the Clinical Genetics Consultation, the Rare Diseases Functional Unit and the Genetics Laboratory.
The Clinical and Molecular Genetics department is a reference centre in Catalonia in the diagnosis and care of patients with rare genetic diseases, and we are also responsible for significant research and teaching activity.
Our clinical genetic consultation offers comprehensive care for patients with genetic illnesses and their families, based on diagnosis, monitoring, management and genetic counselling.
Our main objective is to create a functional unit around a single diagnostic process, covering everything from the clinical point of view to diagnostic testing, for genetic diseases, taking into account their complexity and the need for comprehensive, multidisciplinary treatment.
We have been officially classified as a member of the first Network of Clinical Expertise Units (XUEC) for the treatment of rare diseases in Catalonia, which is devoted to treating genetic cognitive/behavioural illnesses in children. Created by the Catalan Health Service (CatSalut). Thanks to this recognition, the Clinical Expertise Units (UEC) lead the way in diagnosing and caring for those affected by this type of disease in accordance with the criteria and requirements established by the rare diseases protocol in Catalonia.
Care for patients and relatives in the field of genetics includes four main activities:
More specifically, the clinical activity of the genetic consultation relating to diagnosis of genetic disorders is concentrated in a series of specific functional groups that include:
We pursue several lines of research that are part of Vall d'Hebron Research Institute (VHIR) research groups. This includes the Genetic Medicine Research Group and our collaboration with other groups from Oncogenetics, Mitochondrial Diseases, Endocrinology and Paediatric Pneumology.
Our teaching activity covers undergraduates, postgraduates and continuing education of professionals interested in the field, including theoretical classes, academic placements on the unit, and supervision of final year and master's degree projects. Medical staff from our department participate actively in the following master's programmes:
We also organise seminars and courses for different groups, such as nursing professionals, consultants, residents and educators.
In collaboration with the FEDER (the Spanish Rare Diseases Federation), we have set up ourWorkshops for Patients with Rare Diseases: looking beyond the disease.
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.